Paroxysmal hemicrania and POEMS syndrome: further evidence that neuropeptides are implicated in primary headache?
Paviour
D C
DC
Kings College Hospital NHS Trust, London, UK. dpaviour@doctors.org.uk
Ellis
C M
CM
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003967:Diarrhea / Q000150:complications; D017809:Fatal Outcome; D005221:Fatigue / Q000150:complications; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000209:etiology; D007213:Indomethacin / Q000627:therapeutic use; D009479:Neuropeptides; D016878:POEMS Syndrome / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D051302:Paroxysmal Hemicrania / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D011239:Prednisolone / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*; D014786:Vision Disorders / Q000209:etiology
D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D009479:Neuropeptides; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D011239:Prednisolone; D007213:Indomethacin